CN102716309B - Externally dressed drug for treating fracture - Google Patents
Externally dressed drug for treating fracture Download PDFInfo
- Publication number
- CN102716309B CN102716309B CN201110165122.2A CN201110165122A CN102716309B CN 102716309 B CN102716309 B CN 102716309B CN 201110165122 A CN201110165122 A CN 201110165122A CN 102716309 B CN102716309 B CN 102716309B
- Authority
- CN
- China
- Prior art keywords
- parts
- weight parts
- fracture
- grams
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention, relating to the field of traditional Chinese medicine, discloses an externally dressed drug for treating fracture, solving the problems of bad curative effects, slow effect and the like in the prior art by combining modern pharmacological studies based on pathologic knowledge of fracture in traditional Chinese medicine. The drug comprises the following ingredients: 20-60 weight parts of eupolyphaga sinensis, 5-25 weight parts of dragon's blood, 15-40 weight parts of cassia twig, 15-25 weight parts of olibanum, 10-20 weight parts of rhizoma anemarrhenae, 5-15 weight parts of rhizoma corydalis, 10-20 weight parts of myrrh, 5-15 weight parts of cinnabar, 10-30 weight parts of achyranthes bidentata, 5-20 weight parts of pillis ophidiae, and 20-50 weight parts of Panax notoginseng powder. The drug of the invention is used for fracture and bone lesions. After fracture patients use the drug, the wound heals quickly without recurrence, the swelling is reduced quickly, and the pain is alleviated. After the fractures are healed, there is no side effect, and limbs can move normally.
Description
Technical field:
The present invention relates to the field of Chinese medicines, be specially a kind of topical agent for the treatment of fracture.
Background technology:
Fracture is a kind of common outer causing property damage, generally by due to external force, is disease more serious in traumatology.Once after fracturing, can cause whole body or local pain, redness, fracture site deforms or ruptures, walking and generation in life difficulty.
At present, doctor trained in Western medicine generally adopts after reduction, with clamping plate or Gypsum Fibrosum, fixes outward and is aided with necessary interior medicine for external use, and patient suffering is large, and healing is slow.The prescription for the treatment of fracture is a lot, but all has shortcomings:
1, healing time is long;
2, take effect slowly;
3, effect is undesirable, and patient's time that groans is long.
Facts have proved, motherland's medicine and pharmacology are accumulating rich experience aspect treatment fractures, and the traditional Chinese medical science is more emphasized overall treatment, and treating both the principal and secondary aspects of a disease puts prevention first, and Chinese medicine is few and famous with untoward reaction.Therefore, this sick Chinese medicine preparation of development treatment is highly significant with necessity.
Summary of the invention:
The object of the present invention is to provide a kind of topical agent for the treatment of fracture, the pathology understanding based on motherland's medical science to fracture, in conjunction with modern pharmacology research, solves that the curative effect existing in prior art is poor, the problem such as slow takes effect.
To achieve these goals, the present invention adopts following technical scheme:
Treat a topical agent for fracture, meter by weight, medicament consists of: 20～60 parts of Eupolyphaga Seu Steleophagas, 5～25 parts of Sanguis Draxonis, 15～40 parts of Ramulus Cinnamomi, 15～25 parts of Olibanums, 10～20 parts of the Rhizoma Anemarrhenaes, 5～15 parts of Rhizoma Corydalis, 10～20 parts of Myrrhas, 5～15 parts, Cinnabaris, 10～30 parts of Radix Achyranthis Bidentataes, 5～20 parts of Periostracum Serpentiss, 20～50 parts of Radix Notoginseng powder.
The topical agent of described treatment fracture, meter by weight, medicament composition is preferably, 20～40 parts of Eupolyphaga Seu Steleophagas, 10～25 parts of Sanguis Draxonis, 25～35 parts of Ramulus Cinnamomi, 10～15 parts of Olibanums, 15～20 parts of the Rhizoma Anemarrhenaes, 5～10 parts of Rhizoma Corydalis, 20～25 parts of Myrrhas, 5～10 parts, Cinnabaris, 15～20 parts of Radix Achyranthis Bidentataes, 10～15 parts of Periostracum Serpentiss, 20～35 parts of Radix Notoginseng powder.
The topical agent of described treatment fracture, meter by weight, medicament composition is preferably, 25～30 parts of Eupolyphaga Seu Steleophagas, 12～20 parts of Sanguis Draxonis, 28～30 parts of Ramulus Cinnamomi, Olibanum 20-25 part, 15～17 parts of the Rhizoma Anemarrhenaes, 8～10 parts of Rhizoma Corydalis, 10～15 parts of Myrrhas, 10～15 parts, Cinnabaris, 19～20 parts of Radix Achyranthis Bidentataes, 8～10 parts of Periostracum Serpentiss, 30～35 parts of Radix Notoginseng powder.
The topical agent of described treatment fracture, meter by weight, medicament composition is preferably, 30 parts of Eupolyphaga Seu Steleophagas, 15 parts of Sanguis Draxonis, 30 parts of Ramulus Cinnamomi, 15 parts of Olibanums, 15 parts of the Rhizoma Anemarrhenaes, 10 parts of Rhizoma Corydalis, 15 parts of Myrrhas, 10 parts, Cinnabaris, 20 parts of Radix Achyranthis Bidentataes, 10 parts of Periostracum Serpentiss, 30 parts of Radix Notoginseng powder.
Described medicament is Powdered, and Radix Notoginseng powder is powdery, and granularity is about 80-150 order, and the granularity of all the other powder is 8-12 order.
The present invention treats the topical agent of fracture, and every secondary topical agent is got 150-200 gram.Medicament before use, is poured medicament in vinegar into and is stirred, and the part by weight of vinegar and medicament is 50:(150-200), then with gauze parcel, pave rear use, during use, spread on wound; During external application, medicine layer thickness is 0.8～1.2 centimetre, covers the outer rim 3-5 centimetre of super injury place.
Pharmacology analysis of the present invention is as follows:
(1) Eupolyphaga Seu Steleophaga, has anticoagulation and to Fibrinolytic effect, experiment shows: Eupolyphaga Seu Steleophaga has blood coagulation resisting function, the blood supply of major organs, tissue and whole body in energy improvement and reinforcement, Eupolyphaga Seu Steleophaga water extract is to rat oral gavage, and continuous 7 days, energy is prolong rats bleeding time and recalcification time obviously, hematoblastic aggregation rate is had to remarkable inhibitory action, have removing blood stasis with potent drugs blood, the effect of reuniting the fractured tendons and bones, for injured bone, blood stasis amenorrhea, miasma abdominal mass mass in the abdomen.
(2) Sanguis Draxonis, has the effect of promoting blood circulation to remove blood stasis, analgesic therapy, hemostasia and promoting granulation, and zoopery proves, Sanguis Draxonis can significantly shorten plasma in rabbit recalcification time, thereby increases its Blood clotting.< < Haiyao Bencao, Oversea Materia Medica > > records: Sanguis Draxonis is leading traumatics fracture damage, and tonify deficiency and vim and vigour are stirred thorn, and interior blood trouble is poly-.
(3) Ramulus Cinnamomi, has blood vessel dilating, regulates blood circulation, makes blood flow to body surface, reinforcement Herba Ephedrae perspiration.< < book on Chinese herbal medicine converges speech > > to be recorded, and Ramulus Cinnamomi is dispersing wind and cold, by pathogenic factor in the exterior, sends out antiperspirant evil, removes the medicine of wind pain between podomere.Though abnormal smells from the patient is not from hot, body belongs to branch, only can disperse between the fur flesh natural fibre line of meat parade arm knee joint podomere part.
(4) Olibanum, is used for the treatment of regulating qi and activating blood, controls coagulation of QI-blood, trusted subordinate's pain, carbuncle pyogenic infections from tumour or sore, traumatic injury.< < book on Chinese herbal medicine converges says that > > records: the wind of invigorating blood circulation, and the medicine of muscles and tendons relaxing to alleviate pain, falling again beats beats, injured muscles and bones.
(5) Rhizoma Anemarrhenae, belongs to gunpowder under heat clearing away, cures mainly: epidemic febrile disease, high hot excessive thirst, cough and asthma, cough caused by dryness, constipation, osteopyrexia and fever, restlessness of asrhenia type and insomnia, the stranguria with turbid discharge of quenching one's thirst.
(6) Rhizoma Corydalis, regulates the flow of vital energy, invigorates blood circulation, pain relieving, has hemostasis heat-clearing and toxic substances removing, and the effect of promoting blood circulation and stopping pain, is applicable to the light disease of furuncle and phyma.
(7) Myrrha, cures mainly breast abdomen stasis of blood pain, dysmenorrhea, amenorrhea, lump in the abdomen, traumatic injury, carbuncle skin infection, acute appendicitis, conjunctival congestion and swelling pain.There are the effects such as promoting blood circulation and stopping pain, detumescence and promoting granulation.< < Bencao Jingshu > > records: Myrrha bitter in the mouth is flat nontoxic, so flatly should do pungently, and gas should be slightly cold.All malignant boil anal fistula, all forms because the heat in blood stasis of blood is stagnant, is subject to golden sword and flogging trauma to make skin ulcer outward, and also all flesh and blood is subject to disease.Flesh and blood is hindered the stasis of blood and is generated heat and have a pain, and this medicine hardship can be let out, and pungent energy is loose, cold can heat extraction.It is cloudy that water belongs to, and it is cloudy that blood also belongs to, with class from, therefore can enter blood system, dissipating blood stasis blood, control all skin ulcers of heat in blood and soldier so under blood disorder also.
(8) Cinnabaris, relieving convulsion for clearing away heart-fire, the removing toxic substances of calming the nerves.The positive > > of < < book on Chinese herbal medicine records: Cinnabaris enters the heart and can calm the nerves and walk blood vessels, entering lung can sending down the abnormal ascending QI and walk fur, enter spleen and can walk by sputum muscle, enter the feasible stasis of liver and walk fascia, enter kidney and can relieve oedema or abdominal distension through diuresis or purgation heresy and walk bone marrow.
(9) Radix Achyranthis Bidentatae, for bone and muscle strengthening, promoting blood circulation to restore menstrual flow.< < the southern regions of the Yunnan Province book on Chinese herbal medicine > > records: Radix Achyranthis Bidentatae stops muscles and bones pain, strong muscle relaxing muscles and tendons, and only waist knee joint is tingle.
(10) Periostracum Serpentis, for dispeling the wind, calm the frightened, removing toxic substances, nebula removing.
(11) Radix Notoginseng powder, has the effects such as hemostasis, blood circulation promoting and blood stasis dispelling, subduing swelling and relieving pain, strengthening by means of tonics, resisting fatigue, anoxia enduring, defying age, blood fat reducing, blood sugar lowering, raising body's immunity.
Beneficial effect of the present invention:
1, the present invention is used for the treatment of fracture and bone damage, and fracture patient is being used after topical agent of the present invention, and speed of wound healing is fast, is difficult for recurrence;
2, after using, swelling place of wound can be subsided a swelling rapidly, has reduced patient's misery;
3, after fracture healing, without any side effect, limbs can as sick front freedom of movement.
The specific embodiment:
In the present invention, medicament is Powdered, and Radix Notoginseng powder is powdery, and granularity is about 80-150 order, and the granularity of all the other powder is 8-12 order.Every secondary topical agent is got 150-200 gram.Medicament before use, is poured medicament in vinegar into and is stirred, and the part by weight of vinegar and medicament is 50: (150-200), then with gauze parcel, pave rear use, spread on wound during use; During external application, medicine layer thickness is 0.8～1.2 centimetre, covers the outer rim 3-5 centimetre of super injury place.
Embodiment 1
In the present embodiment, the consisting of of medicament: 30 grams of Eupolyphaga Seu Steleophagas, 15 grams of Sanguis Draxonis, 30 grams of Ramulus Cinnamomi, 20 grams of Olibanums, 15 grams of the Rhizoma Anemarrhenaes, 10 grams of Rhizoma Corydalis, 10 grams of Myrrhas, 10 grams, Cinnabaris, 20 grams of Radix Achyranthis Bidentataes, 8 parts of Periostracum Serpentiss, 30 grams of Radix Notoginseng powder; Before use, medicament powder is poured in 50 milliliters of vinegars and stirred, then, with using after gauze parcel, spread on wound (swelling place or bone splits place) upper during use, during external application, medicine layer thickness is 1 centimetre, covers the outer rim 3-5 centimetre of super injury place.
Clinic Case:
Ten thousand so-and-so, female, 45 years old, community work personnel; During skating, fall and cause thoracic vertebra 11,12 compression fracturees, can only lie in bed; Use the embodiment of the present invention 1 external application for curing, within 7 days, change once, i.e. healing in 20 days, can descend and walk after 23 days, within 30 days, recovered afterwards normal.
Embodiment 2
In the present embodiment, the consisting of of medicament: 20 grams of Eupolyphaga Seu Steleophagas, 25 grams of Sanguis Draxonis, 30 grams of Ramulus Cinnamomi, 15 grams of Olibanums, 10 grams of the Rhizoma Anemarrhenaes, 15 grams of Rhizoma Corydalis, 15 grams of Myrrhas, 5 grams, Cinnabaris, 20 grams of Radix Achyranthis Bidentataes, 5 parts of Periostracum Serpentiss, 30 grams of Radix Notoginseng powder; Before use, medicament powder is poured in 50 milliliters of vinegars and stirred, then, with using after gauze parcel, spread on wound (swelling place or bone splits place) upper during use, during external application, medicine layer thickness is 1 centimetre, covers the outer rim 3-5 centimetre of super injury place.
Clinic Case:
Lin, female, 36 years old, certain engineer of coal research branch; In the time of downstairs, do not stand firm, cause the fracture of tarsus of foot, swelling can not be walked, and action is obstructed; Use the embodiment of the present invention 2 external application for curing, within 7 days, change once, i.e. healing in 15 days, can descend and walk after 20 days, within 23 days, recovered afterwards normal.
Embodiment 3
In the present embodiment, the consisting of of medicament: 60 grams of Eupolyphaga Seu Steleophagas, 5 grams of Sanguis Draxonis, 15 grams of Ramulus Cinnamomi, 25 grams of Olibanums, 15 grams of the Rhizoma Anemarrhenaes, 10 grams of Rhizoma Corydalis, 10 grams of Myrrhas, 10 grams, Cinnabaris, 10 grams of Radix Achyranthis Bidentataes, 5 parts of Periostracum Serpentiss, 35 grams of Radix Notoginseng powder; Before use, medicament powder is poured in 50 milliliters of vinegars and stirred, then, with using after gauze parcel, spread on wound (swelling place or bone splits place) upper during use, during external application, medicine layer thickness is 1 centimetre, covers the outer rim 3-5 centimetre of super injury place.
Clinic Case:
Zhang, man 42 years old, carpenter; During work, from the scaffold of approximately 2 meters of height, jump off, cause sufficient root bone fracture, swelling can not be walked; Use the embodiment of the present invention 3 external application for curing, within 7 days, change once, i.e. healing in 17 days, can descend and walk after 20 days, within 25 days, recovered afterwards normal.
Embodiment 4
In the present embodiment, the consisting of of medicament: 30 grams of Eupolyphaga Seu Steleophagas, 10 grams of Sanguis Draxonis, 40 grams of Ramulus Cinnamomi, 15 grams of Olibanums, 20 grams of the Rhizoma Anemarrhenaes, 5 grams of Rhizoma Corydalis, 10 grams of Myrrhas, 5 grams, Cinnabaris, 25 grams of Radix Achyranthis Bidentataes, 5 parts of Periostracum Serpentiss, 20 grams of Radix Notoginseng powder; Before use, medicament powder is poured in 50 milliliters of vinegars and stirred, then, with using after gauze parcel, spread on wound (swelling place or bone splits place) upper during use, during external application, medicine layer thickness is 1 centimetre, covers the outer rim 3-5 centimetre of super injury place.
Embodiment 5
In the present embodiment, the consisting of of medicament: 30 grams of Eupolyphaga Seu Steleophagas, 15 grams of Sanguis Draxonis, 30 grams of Ramulus Cinnamomi, 15 grams of Olibanums, 15 grams of the Rhizoma Anemarrhenaes, 10 grams of Rhizoma Corydalis, 15 grams of Myrrhas, 10 grams, Cinnabaris, 20 grams of Radix Achyranthis Bidentataes, 10 grams of Periostracum Serpentiss, 30 grams of Radix Notoginseng powder; Before use, medicament powder is poured in 50 milliliters of vinegars and stirred, then, with using after gauze parcel, spread on wound (swelling place or bone splits place) upper during use, during external application, medicine layer thickness is 1 centimetre, covers the outer rim 3-5 centimetre of super injury place.
Clinic Case:
Ten thousand so-and-so, man, 31 years old, driver, during unloading, weight is slipped to instep, and big toe is pounded into comminuted fracture, agonizing, swelling cannot be walked; Use the embodiment of the present invention 4 external application for curing, within 7 days, change once, i.e. healing in 19 days, can descend and walk after 20 days, within 25 days, recovered afterwards normal.
Claims (4)
1. a topical agent for the treatment of fracture, is characterized in that, by weight meter, medicament consists of: 20～60 parts of Eupolyphaga Seu Steleophagas, 5～25 parts of Sanguis Draxonis, 15～40 parts of Ramulus Cinnamomi, 15～25 parts of Olibanums, 10～20 parts of the Rhizoma Anemarrhenaes, 5～15 parts of Rhizoma Corydalis, 10～20 parts of Myrrhas, 5～15 parts, Cinnabaris, 10～30 parts of Radix Achyranthis Bidentataes, 5～20 parts of Periostracum Serpentiss, 20～50 parts of Radix Notoginseng powder.
2. according to the topical agent for the treatment of fracture claimed in claim 1, it is characterized in that, by weight meter, medicament consists of, 25～30 parts of Eupolyphaga Seu Steleophagas, 12～20 parts of Sanguis Draxonis, 28～30 parts of Ramulus Cinnamomi, Olibanum 20-25 part, 15～17 parts of the Rhizoma Anemarrhenaes, 8～10 parts of Rhizoma Corydalis, 10～15 parts of Myrrhas, 10～15 parts, Cinnabaris, 19～20 parts of Radix Achyranthis Bidentataes, 8～10 parts of Periostracum Serpentiss, 30～35 parts of Radix Notoginseng powder.
3. according to the topical agent for the treatment of fracture claimed in claim 1, it is characterized in that, meter by weight, medicament consists of, 30 parts of Eupolyphaga Seu Steleophagas, 15 parts of Sanguis Draxonis, 30 parts of Ramulus Cinnamomi, 15 parts of Olibanums, 15 parts of the Rhizoma Anemarrhenaes, 10 parts of Rhizoma Corydalis, 15 parts of Myrrhas, 10 parts, Cinnabaris, 20 parts of Radix Achyranthis Bidentataes, 10 parts of Periostracum Serpentiss, 30 parts of Radix Notoginseng powder.
4. according to the topical agent for the treatment of fracture claimed in claim 1, it is characterized in that, medicament is Powdered, and Radix Notoginseng powder is powdery, and granularity is 80-150 order, and the granularity of all the other powder is 8-12 order.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110165122.2A CN102716309B (en) | 2011-06-20 | 2011-06-20 | Externally dressed drug for treating fracture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110165122.2A CN102716309B (en) | 2011-06-20 | 2011-06-20 | Externally dressed drug for treating fracture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102716309A CN102716309A (en) | 2012-10-10 |
| CN102716309B true CN102716309B (en) | 2014-04-30 |
Family
ID=46942263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110165122.2A Expired - Fee Related CN102716309B (en) | 2011-06-20 | 2011-06-20 | Externally dressed drug for treating fracture |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102716309B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105878768A (en) * | 2014-05-06 | 2016-08-24 | 陈子银 | Preparation method of ointment for treating fracture and rheumatism involving bone |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1127974C (en) * | 2001-09-30 | 2003-11-19 | 吴绍静 | Chinese medicine preparation 'Jiangudan' |
| CN1234402C (en) * | 2003-02-12 | 2006-01-04 | 王戬 | Bone fracture therapeutic pharmaceuticals |
| US20050037094A1 (en) * | 2003-07-31 | 2005-02-17 | Xijun Yan | Composition for heart disease, its active ingredients, method to prepare same and uses thereof |
| CN100396328C (en) * | 2006-07-19 | 2008-06-25 | 李永胜 | Combined medicine for preventing and treating rheumatism, rheumatoid, protrusion of intervertebral disc and hyperosteogeny |
| CN101428121A (en) * | 2007-11-06 | 2009-05-13 | 赵淑珍 | Traditional Chinese medicine liniment for activating blood circulation and removing stasis, dispersing the swelling, relieving pain, relaxing tendons and activating collaterals |
| CN101966316B (en) * | 2009-07-28 | 2015-07-01 | 上海佰加壹医药有限公司 | Gujin pill pellet and preparation method thereof |
-
2011
- 2011-06-20 CN CN201110165122.2A patent/CN102716309B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102716309A (en) | 2012-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102988657B (en) | Plaster for treating fracture and traumatic injury and preparation method of plaster | |
| CN101485853A (en) | Medicament for promoting blood circulation and removing blood stasis | |
| CN103877247B (en) | Medicine being used for the treatment of decubital ulcer and preparation method thereof | |
| CN103055260A (en) | Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof | |
| CN102836307A (en) | Chinese herbal medicine formula for treating traumatic injuries, tendon injuries and fractures | |
| CN103768531B (en) | Chinese medicine composition being used for the treatment of rheumatoid arthritis and preparation method thereof | |
| CN101284109B (en) | Medicine for curing the burnt, scalded and frostbited corium to regenerate | |
| CN103251865A (en) | Traditional Chinese medicine composite for treating diarrhea | |
| CN102451331A (en) | Traditional Chinese preparation for treating barrenness | |
| CN102716309B (en) | Externally dressed drug for treating fracture | |
| CN103156992A (en) | An external application plaster combination for treatment of fracture injuries and a preparation method thereof | |
| CN102895544B (en) | Traditional Chinese medicament for treating postpartum wind-stroke | |
| CN106236964A (en) | A kind of Chinese medicine treating joint disease | |
| CN102145099A (en) | Traditional Chinese medicine for treating infertility caused by liver stagnation | |
| CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
| CN103417788A (en) | Orally taken traditional Chinese medicine for treating fracture | |
| CN104288581A (en) | Traditional Chinese medicine for treating threatened abortion | |
| CN102600359A (en) | Patch for treating abdominal wall endometriosis after cesarean section | |
| CN102552610A (en) | Chinese medicinal composition for treating bone fracture | |
| CN100462093C (en) | Powder for setting a broken bone and preparation method | |
| CN105031180A (en) | Traditional Chinese medicine preparation for treating fever and preparation method thereof | |
| CN105816603A (en) | Traditional Chinese medicine composition for treating postpartum hemorrhage | |
| CN105213732A (en) | A kind of band bed sore ointment and preparation method thereof | |
| CN105194093A (en) | Traditional Chinese medicine composition for treating bone fracture | |
| CN104208611A (en) | External-applying traditional Chinese medicine powder for injuries in bone and tendon and use method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140430 Termination date: 20180620 |